Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
28
MSC Quote, Financials, Valuation and Earnings
Last price:
$5.55
Seasonality move
:
0.3%
Day range:
$5.50 - $5.72
52-week range:
$5.02 - $9.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.75x
P/B ratio:
1.64x
Volume:
1.8K
Avg. volume:
5.1K
1-year change:
-10.84%
Market cap:
$1.1B
Revenue:
$445.5M
EPS (TTM):
-$0.45
Analysts' Opinion
-
Consensus RatingStudio City International Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Studio City International Holdings has an estimated upside of 92.47% from its current price of $5.72.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $5.72.
Fair Value
-
According to the consensus of 0 analysts, Studio City International Holdings has 92.47% upside to fair value with a price target of -- per share.
MSC vs. S&P 500
-
Over the past 5 trading days, Studio City International Holdings has underperformed the S&P 500 by -12.97% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Studio City International Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Studio City International Holdings has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Studio City International Holdings reported revenues of $174.6M.
Earnings Growth
-
Studio City International Holdings has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Studio City International Holdings reported earnings per share of -$0.11.
Enterprise value:
3.2B
EV / Invested capital:
1.11x
Price / LTM sales:
1.75x
EV / EBIT:
65.50x
EV / Revenue:
5.04x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-5.72x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
12.58x
Gross Profit (TTM):
$415.9M
Return On Assets:
-2.82%
Net Income Margin (TTM):
-14.18%
Return On Equity:
-12.62%
Return On Invested Capital:
-2.96%
Operating Margin:
9.16%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $35.8M | $308.5M | $627.5M | $137.6M | $174.6M | |
| Gross Profit | -$44.9M | $157.3M | $415.9M | $86.2M | $113.4M | |
| Operating Income | -$252M | -$106.5M | $30.8M | $10.8M | $16M | |
| EBITDA | -$114.1M | $46.7M | $251.3M | $50.7M | $64.2M | |
| Diluted EPS | -$1.90 | -$1.04 | -$0.45 | -$0.15 | -$0.11 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $694.5M | $712.6M | $680.9M | $380M | $154.1M | |
| Total Assets | $3.1B | $3.3B | $3.7B | $3.3B | $3B | |
| Current Liabilities | $116.6M | $173M | $243M | $131.9M | $152.5M | |
| Total Liabilities | $1.7B | $2.3B | $2.7B | $2.6B | $2.3B | |
| Total Equity | $1.3B | $1B | $961.1M | $740.2M | $671.8M | |
| Total Debt | $1.6B | $2.1B | $2.4B | $2.4B | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2022-03-31 | 2023-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$238.7M | -$130.2M | -$202.5M | -$56.5M | -$80.2M | |
| Cash From Investing | -$257.8M | -$482.2M | -$351.4M | -$160.3M | -$58.3M | |
| Cash From Financing | $743.8M | $696.8M | $297.7M | $345.4M | -- | |
| Free Cash Flow | -$494M | -$609.4M | -$552.6M | -$216.4M | -$138.1M | |
MSC
Sector
Market Cap
$1.1B
$483.3M
Price % of 52-Week High
61.45%
72.36%
Dividend Yield
0%
0%
Shareholder Yield
--
3.61%
1-Year Price Total Return
-10.84%
-11.07%
Beta (5-Year)
-0.418
0.973
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$6.31
200-day SMA
Sell
Level
$6.81
Bollinger Bands (100)
Sell
Level
5.86 - 6.96
Chaikin Money Flow
Sell
Level
-1.1M
20-day SMA
Sell
Level
$6.48
Relative Strength Index (RSI14)
Sell
Level
36.43
ADX Line
Sell
Level
13.78
Williams %R
Buy
Level
-85.6533
50-day SMA
Sell
Level
$6.44
MACD (12, 26)
Sell
Level
-0.11
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
4.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.2996)
Sell
CA Score
(Annual)
Level (-1.6532)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (2.6477)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including 15 tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
Stock Forecast FAQ
In the current month, MSC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MSC average analyst price target in the past 3 months is --.
-
Where Will Studio City International Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Studio City International Holdings share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Studio City International Holdings?
Analysts are divided on their view about Studio City International Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Studio City International Holdings is a Sell and believe this share price will drop from its current level to --.
-
What Is Studio City International Holdings's Price Target?
The price target for Studio City International Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MSC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Studio City International Holdings is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MSC?
You can purchase shares of Studio City International Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Studio City International Holdings shares.
-
What Is The Studio City International Holdings Share Price Today?
Studio City International Holdings was last trading at $5.55 per share. This represents the most recent stock quote for Studio City International Holdings. Yesterday, Studio City International Holdings closed at $5.72 per share.
-
How To Buy Studio City International Holdings Stock Online?
In order to purchase Studio City International Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
